Monash University researchers have gained insights into how nanoparticles could develop a biosensor to prevent deadly diseases contracted on medical equipment, such as catheters.
- Monash University researchers have gained insights into how nanoparticles could develop a biosensor to prevent deadly diseases contracted on medical equipment, such as catheters.
- Candida albicans can become a serious problem for people who are seriously ill or immune-suppressed.
Researchers at Monash University have gained insights into how nanoparticles could be used to identify the presence of invasive and sometimes deadly microbes, and deliver targeted treatments more effectively.
This study was conducted as an interdisciplinary collaboration between microbiologists, immunologists and engineers led by Dr Simon Corrie from Monash University’s Department of Chemical Engineering and Professor Ana Traven from the Monash Biomedicine Discovery Institute (BDI). It was recently published in the American Chemical Society journal ACS Applied Interfaces and Material.
Candida albicans, a commonly found microbe, can turn deadly when it colonises on devices such as catheters implanted in the human body. While commonly found in healthy people, this microbe can become a serious problem for those who are seriously ill or immune-suppressed.
The microbeforms a biofilm when it colonises using, for example, a catheter as a source of infection. It then spreads into the bloodstream to infect internal organs.
“The mortality rate in some patient populations can be as high as 30 to 40 per cent even if you treat people. When it colonises, it’s highly resistant to anti-fungal treatments,” Professor Traven said.
“The idea is that if you can diagnose this infection early, then you can have a much bigger chance of treating it successfully with current anti-fungal drugs and stopping a full-blown systemic infection, but our current diagnostic methods are lacking. A biosensor to detect early stages of colonisation would be highly beneficial.”
The researchers investigated the effects of organosilica nanoparticles of different sizes, concentrations and surface coatings to see whether and how they interacted with both C. albicans and with immune cells in the blood.
They found that the nanoparticles bound to fungal cells, but were non-toxic to them.
“They don’t kill the microbe, but we can make an anti-fungal particle by binding them to a known anti-fungal drug,” Professor Traven said.
The researchers also demonstrated that the particles associate with neutrophils – human white blood cells – in a similar way as they did with C. albicans, remaining noncytotoxic towards them.
“We’ve identified that these nanoparticles, and by inference a number of different types of nanoparticles, can be made to be interactive with cells of interest,” Dr Corrie said.
“We can actually change the surface properties by attaching different things; thereby we can really change the interactions they have with these cells – that’s quite significant.”
Dr Corrie said while nanoparticles were being investigated in the treatment of cancer, the use of nanoparticle-based technologies in infectious diseases lags behind the cancer nanomedicine field, despite the great potential for new treatments and diagnostics.
“The other unique thing in this study is that rather than using cells grown in culture, we’re also looking at how particles act in whole human blood and with neutrophils extracted from fresh human blood,” he said.
Professor Traven said the study had benefited greatly from interdisciplinary collaboration.
“We’ve brought together labs with expertise in infection, microbiology and immunology with a lab that has expertise in engineering, to do state-of-the-art experiments,” she said.
The Latest on: Nanoparticle biosensor
via Google News
The Latest on: Nanoparticle biosensor
- Scientists develop nanoparticle-based biosensing device for rapid and ultrasensitive detection of SARS-CoV-2on August 4, 2022 at 4:26 am
Researchers developed a gold nanoparticle-based biosensing device for rapid and ultrasensitive detection of SARS-CoV-2 in point-of-care settings.
- Aptamer-conjugated Gold Nanoparticles for Bioanalysison August 2, 2022 at 5:00 pm
Nanomedicine. 2013;8(6):983-993. Fan and coworkers reported novel multicolor fluorescent Apt–AuNPs for homogeneous detection of small-molecule targets.  First, the multicolor dye-labeled ...
- New nanoparticle-based material could help detect antibiotics in wateron August 2, 2022 at 4:29 am
Recently, nanoparticle-based 2D materials have gained tremendous interest among researchers and industry due to their mechanical strength, flexibility, and optical and electronic properties which ...
- Biosensors & bioelectronicson July 29, 2022 at 5:00 pm
ion by gold nanoparticles-DNA conjugates. An ultrasensitive electrochemiluminescence biosensor for detection of MicroRNA by in-situ electrochemically generated copper nanoclusters as luminophore ...
- Swiss army vaccines: a multipronged attack against SARS-CoV-2 and other betacoronaviruseson July 20, 2022 at 6:45 am
A nanoparticle vaccine, providing protection from up to eight viral receptor binding domains, is set to enter Phase I clinical trials after promising results in preclinical studies. The 21st century ...
- What is Nanobiotechnology Used For?on July 11, 2022 at 5:01 pm
For example, a nanobiotechnologist might synthesize lipid nanoparticles, functionalize them with drug ... and medical tools that can be utilized in research and the clinic as biosensors, therapeutic ...
- Advanced Manufacturing of Polymers & Soft Materialson April 27, 2022 at 5:27 am
Photoresist polymers for nanolithography, nanofluidic devices & microcapsules & hybrid nanoparticles for nanomedicine, biomedical devices, drug delivery devices and biosensors. Synthesis & ...
- Nanoparticles could enable a more sensitive and durable rapid COVID-19 test (IMAGE)on April 13, 2022 at 5:00 am
A 3D-printed device detects temperature changes when SARS-CoV-2 binds to molecularly imprinted polymer nanoparticles (ruler shows cm). Image may only be used with credit shown.
- Biosensing with plasmonic nanosensorson December 2, 2021 at 6:46 pm
Recent developments have greatly improved the sensitivity of optical sensors based on metal nanoparticle arrays ... significant challenges for plasmonic biosensors: first, pushing sensitivity ...
- Magnetic Nanoparticles in Biosensing and Medicineon April 6, 2021 at 7:37 am
Zavadskiy, Sergey Pavlovich 2020. The classification and modern use of magnetic dosage forms in medicine. Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology), p. 18.
via Bing News